Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:27:26.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is displayed, and the previous government funding lapse notice has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:13:31.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new site-wide banner informs users that a lapse in government funding may cause the information on this website to be out of date and that transactions may not be processed, with links to status updates. The site revision has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:47:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added glossary toggle options (Show glossary / Hide glossary) and updated the page revision to v3.4.0, with capitalization changes in the 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' lines. The previous items ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4') were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T06:32:53.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This reflects the latest build of the page without altering its content.
    Difference
    0.0%
    Check dated 2026-01-14T04:23:13.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer changes include Revision: v3.3.3 being added and the HHS Vulnerability Disclosure text along with Revision: v3.3.2 being removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:05:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.